Zacks9d agobearish
IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%Iovance matches Q1 earnings estimates, but weaker-than-expected Amtagvi and Proleukin sales sent shares down 13% despite revenue growth.
Actualités
Uniquement les titres à fort signal — événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
55last 24h
1682last 7d
314🟢 bullish (7d)
171🔴 bearish (7d)
136publishers
Zacks12d agobearish
Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue EstimatesUltragenyx (RARE) delivered earnings and revenue surprises of -18.96% and -15.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks17d agobearish
Pacira (PCRX) Q1 Earnings Miss EstimatesPacira (PCRX) delivered earnings and revenue surprises of -1.64% and +0.58%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?